Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for INVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 72.64M
March 31, 2026 73.81M
December 31, 2025 74.64M
September 30, 2025 74.77M
June 30, 2025 63.01M
March 31, 2025 62.77M
December 31, 2024 62.66M
September 30, 2024 62.60M
June 30, 2024 62.56M
March 31, 2024 62.80M
December 31, 2023 63.31M
September 30, 2023 64.38M
June 30, 2023 65.22M
March 31, 2023 65.82M
December 31, 2022 69.19M
September 30, 2022 69.78M
June 30, 2022 69.71M
March 31, 2022 69.59M
December 31, 2021 69.57M
September 30, 2021 69.49M
June 30, 2021 69.50M
March 31, 2021 101.41M
December 31, 2020 101.39M
September 30, 2020 101.39M
June 30, 2020 101.39M
Date Value
March 31, 2020 101.32M
December 31, 2019 101.29M
September 30, 2019 101.28M
June 30, 2019 101.27M
March 31, 2019 101.18M
December 31, 2018 101.10M
September 30, 2018 101.04M
June 30, 2018 101.51M
March 31, 2018 101.32M
December 31, 2017 101.90M
September 30, 2017 108.00M
June 30, 2017 109.36M
March 31, 2017 109.20M
December 31, 2016 108.44M
September 30, 2016 109.54M
June 30, 2016 111.47M
March 31, 2016 113.00M
December 31, 2015 115.08M
September 30, 2015 117.42M
June 30, 2015 117.02M
March 31, 2015 116.77M
December 31, 2014 116.30M
September 30, 2014 115.23M
June 30, 2014 113.28M
March 31, 2014 112.52M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Zevra Therapeutics, Inc. 59.34M
Collegium Pharmaceutical, Inc. 32.50M
CorMedix, Inc. 77.67M
ANI Pharmaceuticals, Inc. 22.97M
Corcept Therapeutics, Inc. 107.92M